Regulation of cyclin D1 gene expression
- PMID: 20074063
- DOI: 10.1042/BST0380217
Regulation of cyclin D1 gene expression
Abstract
Cyclin D1 is a key regulator of cell proliferation and its expression is subject to both transcriptional and post-transcriptional regulation. In different cellular contexts, different pathways assume a dominant role in regulating its expression, whereas their disregulation can contribute to overexpression of cyclin D1 in tumorigenesis. Here, we discuss the ability of the NF-kappaB (nuclear factor kappaB)/IKK [IkappaB (inhibitor of NF-kappaB) kinase] pathways to regulate cyclin D1 gene transcription and also consider the newly discovered role of the SNARP (SNIP1/SkIP-associated RNA processing) complex as a co-transcriptional regulator of cyclin D1 RNA stability.
Similar articles
-
Histone deacetylase inhibition down-regulates cyclin D1 transcription by inhibiting nuclear factor-kappaB/p65 DNA binding.Mol Cancer Res. 2005 Feb;3(2):100-9. doi: 10.1158/1541-7786.MCR-04-0070. Mol Cancer Res. 2005. PMID: 15755876
-
Menatetrenone, a vitamin K2 analogue, inhibits hepatocellular carcinoma cell growth by suppressing cyclin D1 expression through inhibition of nuclear factor kappaB activation.Clin Cancer Res. 2007 Apr 1;13(7):2236-45. doi: 10.1158/1078-0432.CCR-06-2308. Clin Cancer Res. 2007. PMID: 17404108
-
Curcumin decreases cell proliferation rates through BTG2-mediated cyclin D1 down-regulation in U937 cells.Int J Oncol. 2005 Jun;26(6):1597-603. Int J Oncol. 2005. PMID: 15870875
-
Regulation and function of IKK and IKK-related kinases.Sci STKE. 2006 Oct 17;2006(357):re13. doi: 10.1126/stke.3572006re13. Sci STKE. 2006. PMID: 17047224 Review.
-
IkappaB kinase complexes: gateways to NF-kappaB activation and transcription.Oncogene. 2006 Oct 30;25(51):6685-705. doi: 10.1038/sj.onc.1209934. Oncogene. 2006. PMID: 17072322 Review.
Cited by
-
Suberoylanilide hydroxamic acid (SAHA) inhibits EGF-induced cell transformation via reduction of cyclin D1 mRNA stability.Toxicol Appl Pharmacol. 2012 Sep 1;263(2):218-24. doi: 10.1016/j.taap.2012.06.012. Epub 2012 Jun 28. Toxicol Appl Pharmacol. 2012. PMID: 22749963 Free PMC article.
-
TREM1 as a novel prognostic biomarker and tumor immune microenvironment evaluator in glioma.Medicine (Baltimore). 2023 Dec 1;102(48):e36410. doi: 10.1097/MD.0000000000036410. Medicine (Baltimore). 2023. PMID: 38050264 Free PMC article.
-
Novel interactions between NFATc1 (Nuclear Factor of Activated T cells c1) and STAT-3 (Signal Transducer and Activator of Transcription-3) mediate G protein-coupled receptor agonist, thrombin-induced biphasic expression of cyclin D1, with first phase influencing cell migration and second phase directing cell proliferation.J Biol Chem. 2012 Jun 29;287(27):22463-82. doi: 10.1074/jbc.M112.362996. Epub 2012 May 6. J Biol Chem. 2012. PMID: 22566696 Free PMC article.
-
Cleavage of NIK by the API2-MALT1 fusion oncoprotein leads to noncanonical NF-kappaB activation.Science. 2011 Jan 28;331(6016):468-72. doi: 10.1126/science.1198946. Science. 2011. PMID: 21273489 Free PMC article.
-
Transcriptional down-regulation of metabolic genes by Gdown1 ablation induces quiescent cell re-entry into the cell cycle.Genes Dev. 2020 Jun 1;34(11-12):767-784. doi: 10.1101/gad.337683.120. Epub 2020 May 7. Genes Dev. 2020. PMID: 32381628 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Research Materials